Pediatr Blood Cancer. 2016 May;63(5):947. doi: 10.1002/pbc.25884. Epub 2016 Jan 6.
Author information
- 1
- Pediatric Clinic, Pediatric Hematology and Oncology, Hospital of the Goethe-University Frankfurt, Frankfurt, Germany.
Comment on
- Treatment of EBV-associated nodular sclerosing Hodgkin lymphoma in a patient with ataxia telangiectasia with brentuximab vedotin and reduced COPP plus rituximab. [Pediatr Blood Cancer. 2015]
- Comment on: Treatment of EBV-Associated Nodular Sclerosing Hodgkin Lymphoma in a Patient With Ataxia Telangiectasia With Brentuximab Vedotin and Reduced COPP Plus Rituximab. [Pediatr Blood Cancer. 2016]
- PMID:
- 26739927
- DOI:
- 10.1002/pbc.25884
- [Indexed for MEDLINE]